2010
9 December 2010
CEO Andrew Witty discusses R&D and drug discovery on BBC Radio 4
 |
On the BBC Radio 4 In Business programme, GSK CEO Andrew Witty talked about how drug discovery and the pharmaceutical industry are changing. |
Listen to Andrew Witty on the In Business programme on BBC iPlayer
1–2 December 2010
Eddie Gray, President GSK Pharma Europe, speaks at FT pharmaceutical conference
 |
The 27th annual FT Global Pharmaceutical & Biotechnology Conference took place in London on 1–2 December 2010. The event brought together thought-leaders from the pharmaceutical industry, patient groups, regulators, health technology assessment (HTA) groups to share insights and discuss the future for healthcare and the role of the pharmaceutical industry. |
Read a summary of Eddie Gray’s comments (PDF)
1 December 2010
CLSA China Conference
 |
Mark Reilly, GM, Pharmaceuticals China & Hong Kong, gave a presentation at the CLSA China Conference on December 1 in New York City. Mark gave an update on GSK’s strategy and progress in its pharmaceuticals business in China. |
Mark Reilly’s presentation (PDF)
22 November 2010
CEO Andrew Witty featured in The World in 2011
 |
In The World in 2011, published in November 2010 by The Economist, Andrew Witty, CEO of GlaxoSmithKline, calls on the pharmaceutical industry to do more with less—and still be innovative. |
Read Andrew Witty's feature in The World in 2011 (PDF)
19 November 2010
Mind the Medicine Gap
 |
In this Open University programme on global access to medicines, Jon Pender of GlaxoSmithKline discusses the importance of intellectual property and why it is a critical mechanism to allow companies to generate funds for reinvestment to help create the medicines of the future. The programme also discusses how pharmaceutical companies can help to tackle neglected tropical diseases and improve access to medicines in developing nations. |
The audio and transcript files are provided courtesy of The Open University.
Listen to the programme (19 mins - 17MB MP3 file)
Read the transcript (PDF)
17 November 2010
GSK nanoparticles research featured on BBC Radio 4
 |
In this BBC Radio feature, Richard Hollingham investigates how a better understanding of the properties of nanoparticles is helping researchers develop some novel medical treatments. He talks to Dr Simon Holland at GlaxoSmithKline about research into using nanoparticles to deliver therapeutic agents to precise locations in the body. |
Listen to the Frontiers feature on BBC iPlayer
10 November 2010
Credit Suisse Healthcare Conference
 |
Andrew Witty, Chief Executive Officer, gave a presentation at the 2010 Annual Credit Suisse Health Care Conference in Phoenix, AZ. The presentation was attended by over 100 institutional investors and portfolio managers. Andrew provided an overview of the progress being made in implementing the company's strategy. |
Andrew Witty’s presentation - PDF
Andrew Witty’s presentation - webcast
22 September 2010
Sanford C. Bernstein Pan-European Strategic Decisions Conference
 |
Julian Heslop (CFO) gave a presentation at the Sanford C. Bernstein 7th Pan-European Strategic Decisions Conference in London. Julian provided an overview of GSK’s Half Year 2010 results and an outlook for the future. |
Julian Heslop's presentation - PDF (1.8Mb)
20 September 2010
Investor Visit to GSK Biologicals, Wavre, Belgium
 |
Dr Thomas Breuer (Senior Vice President, Head of Global Development, GSK Biologicals) presented on GSK’s vaccines business. |
Dr Thomas Breuer's presentation - PDF (2.3Mb)
17 September 2010
Bank of America/Merrill Lynch Global Healthcare Conference
 |
Julian Heslop (CFO) gave a presentation at the BoA/Merrill Lynch Healthcare Conference in London. Julian provided an overview of GSK’s Half Year 2010 results and an outlook for the future. |
Julian Heslop's presentation - PDF (1.8Mb)
23 June 2010
Investor Meeting with John Clarke, President, Worldwide Consumer Healthcare
 |
John Clarke (President, Worldwide Consumer Healthcare), along with senior members of his management team, presented on GSK's Consumer Healthcare business |
John Clarke's presentation - PDF (5.3Mb)
21 June 2010
Investor Visit to GSK Biologicals, Wavre, Belgium
 |
Dr Thomas Breuer (Senior Vice President, Head of Global Development, GSK Biologicals), Martin Andrews (SVP, Global Vaccines Centre of Excellence) and Vincent Brichard (VP & Head of Immunotherapeutics) presented on GSK's vaccines business |
Dr Thomas Breuer's presentation - PDF (3.8Mb)
Martin Andrew's presentation - PDF (3.1Mb)
Vincent Brichard's presentation - PDF (1.6Mb)
June 2010
Slides Presented at Investor Meetings in June
 |
This is a general slide deck presented at investor meetings during June 2010 |
16 June 2010
Goldman Sachs Thirty-First Annual Health Care Conference
|
Andrew Witty gave the keynote speech regarding the Pharmaceutical Industry and GSK's strategy at the Goldman Sachs Thirty-First Annual Health Care Conference in California |
Andrew Witty's presentation - webcast
Andrew Witty's Q & A session - webcast
26 May 2010
Citi Investment Research Global Health Care Conference
 |
Simon Harford (SVP, Finance, Emerging Markets) participated on a panel at the 2010 Citi Investment Research Global Health Care Conference in New York. The panel was entitled "The Opportunities and Challenges of Emerging Markets for Health Care" |
Simon Harford's presentation - PDF (0.5Mb)
13 May 2010
Bank of America/Merrill Lynch Healthcare Conference
 |
Abbas Hussain (President, Emerging Markets) gave a presentation at the BoA/Merrill Lynch Healthcare Conference in New York. Abbas provided an overview of GSK's emerging markets strategy |
Abbas Hussain's presentation - PDF (1.8Mb)
11 May 2010
Exane BNP Paribas Healthcare Conference
 |
Dr Thomas Breuer (Senior Vice President Global Clinical R&D and Vaccine Development, GSK Biologicals) gave a presentation at the Exane BNP Paribas Annual Investor Healthcare Conference in Paris. Thomas provided an overview of GSK's vaccines business and late-stage pipeline |
Thomas Breuer's Exane BNP Paribas presentation - PDF (1.1Mb)
5 May 2010
Bernstein Pharma Conference
 |
David Redfern (Chief Strategy Officer) presented at the Bernstein Pharma Conference: The Pharmaceutical Industry's Solution to the "Patent Cliff" & Other Future Challenges in New York City. David also participated on a panel on the outlook for mergers and acquisitions attended by over 100 investors |
David Redfern's presentation - PDF (650Kb)
10 March 2010
Cowen Health Care Conference
|
Julian Heslop (CFO) gave a presentation at the Cowen and Company 30th Annual Health Care Conference in Boston. Julian provided an overview of GSK's 2009 results and an outlook for the future |
Julian Heslop's presentation - webcast
Julian Heslop's presentation - PDF (1.48Mb)
12 Jan 2010
JP Morgan 28th Annual Healthcare Conference
 |
Andrew Witty (CEO) gave a presentation to investors at the JP Morgan 28th Annual Healthcare Conference in San Francisco. Andrew provided an overview of the progress being made in implementing the company's strategy |
Andrew Witty's JP Morgan presentation - PDF (1.61Mb)